Showing results (2711-2720 of 6,517) with videos related to
Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|November 11, 2017
The class I/IV HDAC inhibitor mocetinostat increases tumor antigen presentation, decreases immune suppressive cell types and augments checkpoint inhibitor therapyDavid Briere, Niranjan Sudhakar, David M Woods, et al.Cancer Immunology, Immunotherapy : CII|December 6, 2017
Combination of mAb-AR20.5, anti-PD-L1 and PolyICLC inhibits tumor progression and prolongs survival of MUC1.Tg mice challenged with pancreatic tumorsKamiya Mehla, Jarrod Tremayne, James A Grunkemeyer, et al.Cancer Immunology, Immunotherapy : CII|December 6, 2017
Post-treatment neutrophil-to-lymphocyte ratio at week 6 is prognostic in patients with advanced non-small cell lung cancers treated with anti-PD-1 antibodyKoung Jin Suh, Se Hyun Kim, Yu Jung Kim, et al.Cancer Immunology, Immunotherapy : CII|December 9, 2017
Haploidentical natural killer cells induce remissions in non-Hodgkin lymphoma patients with low levels of immune-suppressor cellsVeronika Bachanova, Dhifaf Sarhan, Todd E DeFor, et al.Cancer Immunology, Immunotherapy : CII|December 20, 2017
IL-6 and IL-10 are associated with good prognosis in early stage invasive breast cancer patientsNarmeen Ahmad, Aula Ammar, Sarah J Storr, et al.Cancer Immunology, Immunotherapy : CII|December 23, 2017
Cytosolic high-mobility group box protein 1 (HMGB1) and/or PD-1+ TILs in the tumor microenvironment may be contributing prognostic biomarkers for patients with locally advanced rectal cancer who have undergone neoadjuvant chemoradiotherapyChih-Yang Huang, Shu-Fen Chiang, Tao-Wei Ke, et al.Cancer Immunology, Immunotherapy : CII|December 1, 2017
Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMECJürgen C Becker, Andreas Stang, Axel Zur Hausen, et al.Cancer Immunology, Immunotherapy : CII|October 24, 2017
NY-ESO-1- and survivin-specific T-cell responses in the peripheral blood from patients with gliomaZhenjiang Liu, Thomas Poiret, Oscar Persson, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1989
Inhibition of murine hepatic tumor growth by liposomes containing a lipophilic muramyl dipeptideP Brodt, J Blore, N C Phillips, et al.Cancer Immunology, Immunotherapy : CII|November 3, 2017
BRAF peptide vaccine facilitates therapy of murine BRAF-mutant melanomaQi Liu, Hongda Zhu, Yun Liu, et al.Pageof 652